Susan E. Graf

CIK: 0001577637

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

AARD

Aardvark Therapeutics, Inc.

Director

CGON

CG Oncology, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (5 total)

AARD
Aardvark Therapeutics, Inc.
Aug 14, 2026
Award(A)
Stock Option (right to buy)
Direct
45K shares-
CGON
CG Oncology, Inc.
Jun 4, 2026
Award(A)
Director Stock Option (right to buy)
Direct
9.4K shares-
AARD
Aardvark Therapeutics, Inc.
Jun 11, 2025
Award(A)
Stock Option (right to buy)
Direct
30.5K shares-
CGON
CG Oncology, Inc.
Jun 5, 2025
Award(A)
Director Stock Option (right to buy)
Direct
24.2K shares-
CGON
CG Oncology, Inc.
Oct 4, 2024
Award(A)
Stock Option (Right to Buy)
Direct
15.6K shares-

		Type	Shares	Price		Ownership
Aug 14, 2026	AARD Aardvark Therapeutics, Inc.	Award(A) Stock Option (right to buy)	44,964	-	-	Direct
Jun 4, 2026	CGON CG Oncology, Inc.	Award(A) Director Stock Option (right to buy)	9,354	-	-	Direct
Jun 11, 2025	AARD Aardvark Therapeutics, Inc.	Award(A) Stock Option (right to buy)	30,508	-	-	Direct
Jun 5, 2025	CGON CG Oncology, Inc.	Award(A) Director Stock Option (right to buy)	24,165	-	-	Direct
Oct 4, 2024	CGON CG Oncology, Inc.	Award(A) Stock Option (Right to Buy)	15,600	-	-	Direct

1-5 of 5 transactions

About Graf Susan E

Graf Susan E (SEC CIK 0001577637) files insider reports with the SEC as Director of Aardvark Therapeutics, Inc. (AARD) and Director of CG Oncology, Inc. (CGON).

Signal8 holds 6 ownership filings by Graf Susan E (1 Form 3, 5 Form 4), filed between Oct 7, 2024 and Aug 21, 2026. Those filings report 5 transactions, from Oct 4, 2024 to Aug 14, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Graf Susan E's filings is in SAN DIEGO, CA.

Recent filings by Graf Susan E

Aug 14, 2026: Grant or award of AARD derivative securities (Form 4, code A).
Jun 4, 2026: Grant or award of CGON derivative securities (Form 4, code A).
Jun 11, 2025: Grant or award of AARD derivative securities (Form 4, code A).
Jun 5, 2025: Grant or award of CGON derivative securities (Form 4, code A).
Oct 4, 2024: Grant or award of CGON derivative securities (Form 4, code A).

Other insiders filing for Aardvark Therapeutics, Inc. (AARD)

Zhang Zhongwei, Director
Sun Nelson
Chi Jeffrey, Director
Baynes Roy D., Director
Tong Victor Edward Jr, Director
Jaiman Manasi, Chief Medical Officer

How to read Form 4 transaction codes